KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Current Deferred Revenue (2019 - 2025)

Teladoc Health's Current Deferred Revenue history spans 7 years, with the latest figure at $71.4 million for Q4 2025.

  • For Q4 2025, Current Deferred Revenue fell 9.9% year-over-year to $71.4 million; the TTM value through Dec 2025 reached $71.4 million, down 9.9%, while the annual FY2025 figure was $71.4 million, 9.9% down from the prior year.
  • Current Deferred Revenue for Q4 2025 was $71.4 million at Teladoc Health, up from $70.1 million in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $121.6 million in Q2 2023 and bottomed at $70.1 million in Q3 2025.
  • The 5-year median for Current Deferred Revenue is $92.9 million (2022), against an average of $93.7 million.
  • The largest annual shift saw Current Deferred Revenue soared 64.59% in 2021 before it crashed 36.39% in 2025.
  • A 5-year view of Current Deferred Revenue shows it stood at $75.6 million in 2021, then surged by 50.57% to $113.8 million in 2022, then fell by 3.96% to $109.3 million in 2023, then dropped by 27.44% to $79.3 million in 2024, then fell by 9.9% to $71.4 million in 2025.
  • Per Business Quant, the three most recent readings for TDOC's Current Deferred Revenue are $71.4 million (Q4 2025), $70.1 million (Q3 2025), and $74.7 million (Q2 2025).